World's Best Scientists 2026 revealed!

D-Index & Metrics

Social Sciences and Humanities

D-Index
48
Citations
8884
World Ranking
3169
National Ranking
33

Overview

Mondher Toumi is affiliated with Aix-Marseille University in France and has an extensive research portfolio spanning medicine and economics. Their work includes 147 publications in medicine and 125 in economics, econometrics, and finance.

The scientist's research interests focus on several subfields including economics and econometrics, physiology, infectious diseases, epidemiology, and oncology. Their main topics of study encompass health systems, economic evaluations, quality of life, pharmaceutical economics and policy, biomedical ethics and regulation, biosimilars and bioanalytical methods, vaccine coverage and hesitancy, COVID-19 clinical research studies, and the broader impacts of COVID-19 on healthcare.

Frequent co-authors include:

  • Samuel Aballéa
  • E. Clay
  • Michał Pochopień
  • Shuyao Liang
  • Laurent Boyer

They have published frequently in several venues, particularly:

  • Value in Health
  • Journal of Market Access & Health Policy
  • Value in Health Regional Issues
  • Preprints.org
  • bioRxiv (Cold Spring Harbor Laboratory)

Notable recent papers include:

  • The real-life impact of vaccination on COVID-19 mortality in Europe and Israel, 2021, Public Health
  • Managed Entry Agreements: Policy Analysis From the European Perspective, 2020, Value in Health
  • Stigma in visible skin diseases - a literature review and development of a conceptual model, 2021, Journal of the European Academy of Dermatology and Venereology
  • Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions, 2020, Drug Discovery Today
  • Chinese guidelines related to novel coronavirus pneumonia, 2020, Journal of Market Access & Health Policy

Best Publications

  • Rates and correlates of employment in people with schizophrenia in the UK, France and Germany

    Steven Marwaha;Sonia Johnson;Paul Bebbington;Mai Stafford

  • Relapse in schizophrenia: costs, clinical outcomes and quality of life

    Stephen Almond;Martin Knapp;Clement Francois;Mondher Toumi

  • Humanistic burden in schizophrenia: A literature review

    A. Millier;U. Schmidt;M.C. Angermeyer;D. Chauhan

  • Burden on caregivers of people with schizophrenia: comparison between Germany and Britain

    Christiane Roick;Dirk Heider;Paul E Bebbington;Matthias C Angermeyer

  • Advanced therapy medicinal products: current and future perspectives

    Eve Hanna;Cécile Rémuzat;Pascal Auquier;Mondher Toumi

  • The impact of caregivers' characteristics, patients' conditions and regional differences on family burden in schizophrenia: a longitudinal analysis.

    C. Roick;D. Heider;M. Toumi;M. C. Angermeyer

  • Gene therapies development: slow progress and promising prospect.

    Eve Hanna;Cécile Rémuzat;Pascal Auquier;Mondher Toumi

  • Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA

    Samuel Aballéa;Florent Guelfucci;Julian Wagner;Amine Khemiri

  • Overview of external reference pricing systems in Europe.

    Cécile Rémuzat;Duccio Urbinati;Olfa Mzoughi;Emna El Hammi

  • Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group.

    Sandra Nestler-Parr;Daria Korchagina;Mondher Toumi;Chris L. Pashos

  • Measuring the health-related quality of life in young children: how far have we come?

    Nicola Germain;Samuel Aballéa;Mondher Toumi

  • Factors contributing to frequent use of psychiatric inpatient services by schizophrenia patients.

    Christiane Roick;Dirk Heider;Reinhold Kilian;Herbert Matschinger

  • The real-life impact of vaccination on COVID-19 mortality in Europe and Israel.

    Katarzyna Jabłońska;Samuel Aballéa;Mondher Toumi

  • Key drivers for market penetration of biosimilars in Europe.

    Cécile Rémuzat;Julie Dorey;Olivier Cristeau;Dan Ionescu

  • The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC).

    Giuseppe Carrà;Sonia Johnson;Paul Bebbington;Matthias C. Angermeyer

  • A prospective study of Quality of life in schizophrenia in three European countries

    Dirk Heider;Matthias C. Angermeyer;Ines Winkler;Georg Schomerus

  • The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study.

    Paul E. Bebbington;Matthias Angermeyer;Jean-Michel Azorin;Traolach Brugha

  • Managed Entry Agreements: Policy Analysis From the European Perspective.

    Monique Dabbous;Lylia Chachoua;Aleksandra Caban;Mondher Toumi

  • Quality of life is predictive of relapse in schizophrenia

    Laurent Boyer;Aurelie Millier;Emeline Perthame;Samuel Aballea

  • Systematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorder

    Nadia Bakkour;Jennifer Samp;Kasem Akhras;Emna El Hammi

  • Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.

    Paul Bebbington;M. Angermeyer;J.-M. Azorin;Steven Marwaha

  • Correlates of subjective quality of life in people with schizophrenia: findings from the EuroSC study.

    Steven Marwaha;Sonia Johnson;Paul Bebbington;Matthias C. Angermeyer

  • Relapse in schizophrenia: costs, clinical outcomes Relapse in schizophrenia: costs, clinical outcomes and quality of life and quality of life

    Stephen Almond;Martin Knapp;Clement Fr Ancois;Mondher Toumi

Frequent Co-Authors

Pascal Auquier
Pascal Auquier Aix-Marseille University
Jean-Michel Azorin
Jean-Michel Azorin Aix-Marseille University
Christophe Lançon
Christophe Lançon Aix-Marseille University
Georg Schomerus
Georg Schomerus Leipzig University
Jeff Richardson
Jeff Richardson Monash University
Erik Nord
Erik Nord Norwegian Institute of Public Health
Søren Holm
Søren Holm University of Manchester
Pierre-Michel Llorca
Pierre-Michel Llorca University of Clermont Auvergne
Hans-Helmut König
Hans-Helmut König Universität Hamburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The evolving landscape of Social Sciences and Humanities offers students a variety of flexible, accredited online degrees designed to launch and advance rewarding careers. For those interested in making a direct impact on communities, accelerated online msw programs provide a fast-track option for earning a Master's in Social Work, leading to roles in clinical settings, schools, and non-profit organizations.

Psychology is another in-demand field, and students can now pursue an accelerated psychology degree online to quickly access diverse job opportunities in counseling, research, or human resources. If you are considering a specialized counseling career, it’s essential to check for cacrep accreditation, which ensures the program meets rigorous professional standards and enhances your eligibility for licensure.

For those focused on family dynamics and interpersonal relationships, a masters in marriage and family therapy online equips graduates to become licensed therapists. These flexible online pathways make it easier to balance studies with work or personal obligations while building a meaningful and impactful career.

Best Scientists Citing Mondher Toumi

Trending Scientists

Recently Published Articles